Chronic Carvedilol in Pediatric Dilated Cardiomyopathy: How Should We Interpret Long-Term Tolerability?
Pediatric Cardiology · 18.09.2026
DOI: 10.1007/s00246-026-04493-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Cardiology, online erschienen am 18.09.2026. Verfasst von Şeyma Şebnem Ön. Beteiligte Einrichtung: Department of pediatric cardiology, Izmir State Hospital, Izmir, Turkey. dr.sebnem.on@gmail.com. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of pediatric cardiology, Izmir State Hospital, Izmir, Turkey. dr.sebnem.on@gmail.com.
ORCID-Profile: Şeyma Şebnem Ön
Zitieren
APA
Ön, Ş. Ş. (2026). Chronic Carvedilol in Pediatric Dilated Cardiomyopathy: How Should We Interpret Long-Term Tolerability?. Pediatric Cardiology. https://doi.org/10.1007/s00246-026-04493-9
Vancouver
Ön ŞŞ. Chronic Carvedilol in Pediatric Dilated Cardiomyopathy: How Should We Interpret Long-Term Tolerability?. Pediatric Cardiology. 2026. doi:10.1007/s00246-026-04493-9
BibTeX
@article{n2026,
author = {Ön, Şeyma Şebnem},
title = {Chronic Carvedilol in Pediatric Dilated Cardiomyopathy: How Should We Interpret Long-Term Tolerability?},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-026-04493-9}
}
EUVIMED